NHIC
NASDAQNewHold Investment Corp III
IPO2025
Price$10.81+0.01 (+0.09%)
01:45 PM07:45 PM
News · 26 weeks15+100%
2026-01-252026-07-19
Mix1390d
- SEC Filings6(46%)
- Other5(38%)
- Earnings1(8%)
- Leadership1(8%)
Latest news
25 items- PRnewcleo advances MOX fuel licensing in France and enters new collaboration phase with French authoritiesASNR considers as satisfactory the safety program proposed by newcleo for its planned MOX fuel facility. The Company will incorporate the insights gained through the ASNR opinion in the ongoing development and planning of its project.SGPI informs the Company that the amount of money raised by newcleo along with its level of development has surpassed the scope of the France 2030 program, leading to different forms of collaboration with French institutions. PARIS, July 17, 2026 (GLOBE NEWSWIRE) -- newcleo (or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced a significant regulatory milestone for its planned mixed-oxide
- SECSEC Form 425 filed by NewHold Investment Corp III425 - NewHold Investment Corp. III (0002043699) (Subject)
- PRNewHold Investment Corp. III and newcleo Ltd. Announce Filing of Registration Statement on Form F-4 with the SEC in Connection With Proposed Business CombinationProposed Nasdaq listing under ticker symbol NWCL in connection with business combination The transaction is expected to be completed in the second half of 2026, subject to customary closing conditions. PARIS and NEW YORK, July 07, 2026 (GLOBE NEWSWIRE) -- NewHold Investment Corp. III (NASDAQ:NHIC) ("NewHold"), and newcleo Ltd. ("newcleo"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced that newcleo filed a registration statement on Form F-4 (as may be amended, the "Registration Statement") with the U.S. Securities and Exchange Commission ("SEC") on July 6, 2026 in connection with their previously announced proposed business combina
- PRnewcleo to acquire nuclear scales manufacturer Bonifait Pesage, strengthening its vertical integrationPARIS, July 01, 2026 (GLOBE NEWSWIRE) -- newcleo (or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced it has entered into an agreement to acquire Bonifait Pesage, a French manufacturer of nuclear-grade scales and precision industrial weighing equipment with a strong customer base in the French nuclear ecosystem. The acquisition forms part of newcleo’s vertical integration strategy, pursued since 2023 through the acquisitions of the EPCM and manufacturing companies Fucina, SRS and Rütschi. It will bring critical manufacturing capabilities in-house, secure preferred access to the nuclear-grade weighing equipment require
- PRSHINE and newcleo Partner to Advance U.S. Spent Nuclear Fuel RecyclingPartnership links SHINE's U.S. recycling capabilities with newcleo's reactors, designed to run on recycled fuel JANESVILLE, Wis. and PARIS, June 17, 2026 (GLOBE NEWSWIRE) -- SHINE, a fusion energy company with a platform expanding into nuclear fuel recycling, and newcleo, a developer of advanced nuclear reactors and fuel, today announced an agreement to collaborate on advancing innovative technologies for the recycling of used nuclear fuel. The Companies will assess how SHINE could supply newcleo with materials from the used nuclear fuel of traditional reactors to manufacture MOX fuel, and how SHINE could recycle spent fuel from newcleo's reactors. The Companies also intend to jointly pu
- PRnewcleo Strengthens U.S. Leadership Team with Strategic Appointments of Dustin Greenwood and Travis ChapmanNEW YORK, June 11, 2026 (GLOBE NEWSWIRE) -- newcleo ("newcleo", or the "Company"), a pioneer in advanced modular reactor ("AMR") technology and nuclear fuel manufacturing, today announced the appointments of two accomplished nuclear industry leaders to key positions within its growing U.S. organization. Dustin Greenwood has joined the Company as Vice President of U.S. Operations and Travis Chapman has been appointed Director of U.S. Regulatory Affairs and Licensing. The strategic appointments mark an important milestone in newcleo's U.S. expansion, reinforcing the Company's commitment to advancing next-generation nuclear technologies and establishing a strong operational and regulatory fo
- SECNewHold Investment Corp III filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - NewHold Investment Corp. III (0002043699) (Filer)
- SECSEC Form 425 filed by NewHold Investment Corp III425 - NewHold Investment Corp. III (0002043699) (Subject)
- SECSEC Form 425 filed by NewHold Investment Corp III425 - NewHold Investment Corp. III (0002043699) (Subject)
- SECNewHold Investment Corp III filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - NewHold Investment Corp. III (0002043699) (Filer)
- PRnewcleo, A Developer of Advanced Nuclear Reactors and Nuclear Fuel, to Become Public Company Through Business Combination with NewHold Investment Corp IIINewcleo Ltd. ("newcleo" or the "Company") is an established nuclear energy company developing advanced modular, lead-cooled fast reactors (LFRs) and mixed oxide (MOX) nuclear fuel from reprocessed nuclear materials.newcleo ranked as a leading advanced modular reactor company in Europe in an independent review by the OECD Nuclear Energy Agency, reflecting the maturity of its technology, fuel strategy, and project development progress.The proposed business combination is intended to accelerate newcleo's US growth strategy, including leveraging its established European projects as a foundation for execution and deployment.newcleo operates in seven countries, with over 900 employees and generate
- SECSEC Form 10-Q filed by NewHold Investment Corp III10-Q - NewHold Investment Corp. III (0002043699) (Filer)
- SECSEC Form NT 10-Q filed by NewHold Investment Corp IIINT 10-Q - NewHold Investment Corp. III (0002043699) (Filer)
- SECSEC Form 10-K filed by NewHold Investment Corp III10-K - NewHold Investment Corp. III (0002043699) (Filer)
- SECSEC Form NT 10-K filed by NewHold Investment Corp IIINT 10-K - NewHold Investment Corp. III (0002043699) (Filer)
- SECSEC Form 10-Q filed by NewHold Investment Corp III10-Q - NewHold Investment Corp. III (0002043699) (Filer)
- SECSEC Form SCHEDULE 13G filed by NewHold Investment Corp IIISCHEDULE 13G - NewHold Investment Corp. III (0002043699) (Subject)
- SECSEC Form 10-Q filed by NewHold Investment Corp III10-Q - NewHold Investment Corp. III (0002043699) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by NewHold Investment Corp IIISCHEDULE 13G/A - NewHold Investment Corp. III (0002043699) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by NewHold Investment Corp IIISCHEDULE 13G/A - NewHold Investment Corp. III (0002043699) (Subject)
- SECSEC Form SCHEDULE 13G filed by NewHold Investment Corp IIISCHEDULE 13G - NewHold Investment Corp. III (0002043699) (Subject)
- SECSEC Form SCHEDULE 13G filed by NewHold Investment Corp IIISCHEDULE 13G - NewHold Investment Corp. III (0002043699) (Subject)
- SECSEC Form SCHEDULE 13G filed by NewHold Investment Corp IIISCHEDULE 13G - NewHold Investment Corp. III (0002043699) (Subject)
- INSIDERSEC Form 3 filed by new insider Baynes-Reid Charlie3 - NewHold Investment Corp. III (0002043699) (Issuer)
- INSIDERSEC Form 3 filed by new insider Sullivan Thomas J.3 - NewHold Investment Corp. III (0002043699) (Issuer)
NHIC FAQ
4 questionsWhere does NHIC stock trade?
NewHold Investment Corp III (NHIC) is listed on NASDAQ.When did NewHold Investment Corp III go public?
NewHold Investment Corp III (NHIC) completed its IPO in 2025.What are analysts saying about NHIC?
NewHold Investment Corp III has had 1 recent analyst action on file. The most recent action was from Northland Capital Markets: Outperform with a $1600.00 price target on 2021-06-29. Recent price targets cluster around $1600.00.How can I track NHIC on Quantisnow?
Quantisnow aggregates NewHold Investment Corp III's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow NHIC to receive live email and push alerts on every new disclosure.